LOS ANGELES--(BUSINESS WIRE)--AmCyte Inc. (www.amcyte.com), a leader in encapsulated islet replacement and pancreatic adult stem cells, announced it will present research and development data from its Regenerated Islet Program at the 7th Annual Rachmiel Levine Diabetes and Obesity Symposium, Advances in Diabetes Research: From Cell Biology to Cell Therapy.